文献速递胸部肿瘤

染色体碎裂介导的小细胞肺癌

Chromothripsis-Mediated Small Cell Lung Carcinoma.
PubMed 文献 · Cancer Discov · 2025-01-01

该研究对缺乏RB1和TP53共失活、发生于从不吸烟或轻度吸烟者的非典型小细胞肺癌(SCLC)进行临床病理、基因组和转录组分析,发现多数病例涉及11或12号染色体的染色体碎裂,导致CCND1或CCND2/CDK4/MDM2的染色体外扩增,并与肺类癌存在基因组和病理联系,提示一种新的SCLC发病模式。

要点

  • 非典型SCLC缺乏RB1/TP53共失活,多见于从不吸烟或轻度吸烟者。
  • 多数病例有11或12号染色体碎裂,致CCND1或CCND2/CDK4/MDM2扩增。
  • 这些肿瘤与肺类癌有基因组和病理联系,提示由低级别神经内分泌肿瘤转化。

核心结论

  • 非典型SCLC是缺乏RB1/TP53改变、以广泛染色体碎裂和与肺类癌病原学联系为特征的新型肺癌实体。

研究设计与样本

  • 对缺乏RB1和TP53共失活、发生于从不吸烟或轻度吸烟者的非典型SCLC进行临床病理、基因组和转录组分析。

主要发现

  • 多数非典型SCLC病例涉及11或12号染色体碎裂,分别导致CCND1染色体外扩增或CCND2/CDK4/MDM2共扩增。
  • 这些临床侵袭性肿瘤与肺类癌存在基因组和病理联系,提示经低级别神经内分泌肿瘤或其前体转化而来。
  • 从不吸烟者中具有RB1和TP53失活的SCLC表现出腺癌向SCLC转化的特征,支持从不吸烟者SCLC存在两种不同的可塑性致病途径。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Small cell lung carcinoma (SCLC) is a highly aggressive malignancy that is typically associated with tobacco exposure and inactivation of RB1 and TP53 genes. Here, we performed detailed clinicopathologic, genomic, and transcriptomic profiling of an atypical subset of SCLC that lacked RB1 and TP53 co-inactivation and arose in never/light smokers. We found that most cases were associated with chromothripsis-massive, localized chromosome shattering-recurrently involving chromosome 11 or 12 and resulting in extrachromosomal amplification of CCND1 or co-amplification of CCND2/CDK4/MDM2, respectively. Uniquely, these clinically aggressive tumors exhibited genomic and pathologic links to pulmonary carcinoids, suggesting a previously uncharacterized mode of SCLC pathogenesis via transformation from lower-grade neuroendocrine tumors or their progenitors. Conversely, SCLC in never-smokers harboring inactivated RB1 and TP53 exhibited hallmarks of adenocarcinoma-to-SCLC derivation, supporting two distinct pathways of plasticity-mediated pathogenesis of SCLC in never-smokers. Significance: Here, we provide the first detailed description of a unique SCLC subset lacking RB1/TP53 alterations and identify extensive chromothripsis and pathogenetic links to pulmonary carcinoids as its hallmark features. This work defines atypical SCLC as a novel entity among lung cancers, highlighting its exceptional histogenesis, clinicopathologic characteristics, and therapeutic vulnerabilities. See related commentary by Nadeem and Drapkin, p. 8.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Rekhtman N, Tischfield SE, Febres-Aldana CA, et al. Chromothripsis-Mediated Small Cell Lung Carcinoma. Cancer Discov. 2025. PMID: 39185963. doi:10.1158/2159-8290.CD-24-0286

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。